Cite

HARVARD Citation

    Dotti, A. et al. (n.d.). P586 Vedolizumab in Mild to Moderate Crohn's Disease Patients Naïve to Biological Therapy: a Multicentric Observational Study. Journal of Crohn's and colitis. pp. i714-i715. [Online]. 
  
Back to record